HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000108 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 20, 2026 |
| Document | View SEC Filing |
Transactions
17
Total Shares
180,000
Total Value
$8,484,791.92
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 17, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 17, 2026 | Sale | 900 | $98.96 | $89,062.20 | 786,880 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 17, 2026 | Sale | 500 | $100.46 | $50,228.50 | 786,380 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 17, 2026 | Sale | 2,100 | $101.77 | $213,708.60 | 784,280 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 17, 2026 | Sale | 9,000 | $102.55 | $922,977.00 | 775,280 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 17, 2026 | Sale | 7,500 | $103.48 | $776,115.00 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 18, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 18, 2026 | Sale | 5,703 | $103.08 | $587,882.35 | 782,077 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 18, 2026 | Sale | 4,897 | $104.11 | $509,826.67 | 777,180 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 18, 2026 | Sale | 9,400 | $104.87 | $985,815.60 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 19, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 19, 2026 | Sale | 7,200 | $106.36 | $765,777.60 | 780,580 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 19, 2026 | Sale | 9,600 | $107.22 | $1,029,350.40 | 770,980 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 19, 2026 | Sale | 3,200 | $107.77 | $344,848.00 | 767,780 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Aug 17, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 181,552 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Aug 18, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 161,552 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Aug 19, 2026 | Exercise/Conversion | 20,000 | $18.41 | $368,200.00 | 141,552 | Direct | โ | View Details |